Share The Graft
Share to email
Share to Facebook
Share to X
By The EBMT Trainee Committee
3
11 ratings
The podcast currently has 32 episodes available.
ALL EPISODES AS VIDEO
FOLLOW MLL
FOLLOW Daniela Twitter: @HermelinMD https://www.bloodcenter.org/about/news/authors/daniela-hermelin-md-a7/ https://www.blooducation.com/about-dr-hermelin ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan
https://twitter.com/AbbasiMuqtadir
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell therapy to treat cancers of the blood, including Non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple myeloma. Her focus is in the development of phase I clinical trials. She is also interested in patient safety, particularly in optimizing patient safety for cellular immunotherapies.
Nico Gagelmann and Jennifer Brudno
ALL EPISODES AS AUDIO
APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846
SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab
GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw==
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
Heslop is a professor of medicine and pediatrics and holds the Dan L Duncan Chair at Baylor. She is a physician-scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells to improve hemopoietic stem cell transplantation and cancer therapy. She has extensive experience in developing and conducting transplant studies and cell and gene therapy studies and currently holds more than 20 Investigational New Drug Applications. She also has played a major role nationally as president of societies focusing on the intellectual and clinical development of cellular therapies and accreditation of facilities delivering cell therapies. Dr. Helen Heslop has been elected to the National Academy of Medicine. She is among 90 regular members and 10 international members announced today at the Academy’s annual meeting.
Dr. Mohyuddin completed his medical training at Aga Khan University in Pakistan and his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. He completed his fellowship developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods end of life, cost-effective/evidence based care and medical education. He enjoys the outdoors, and that drew him to life in Utah where he is currently Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.
Nikita Mehra (@DrNikitaMehra) is an Associate Professor at Medical Oncology and Researcher in Molecular Oncology in the Cancer Institute (WIA), Chennai, India.
Dr. Raffaella Greco (@RaffaellaGrecoM) is a hematologist in the Department of Hematology and Bone Marrow Transplantation at the IRCCS Ospedale San Raffaele under the supervision of Professor Fabio Ciceri. After graduating in 2008 from the Faculty of Medicine and Surgery of the University of Milan Vita-Salute San Raffaele received a specialization in hematology at the same university in 2014.
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan
The podcast currently has 32 episodes available.